Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Leukemia and Lymphoma

Volumn 55, Issue 9, 2014, Pages 2079-2084

  Conte, Michael J ^a   Bowen, Deborah A ^a   Wiseman, Gregory A ^a   Rabe, Kari G ^a   Slager, Susan L ^a   Schwager, Susan M ^a   Call, Timothy G ^a   Viswanatha, David S ^a   Zent, Clive S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic lymphocytic leukemia; CT; Imaging; PET; Small lymphocytic lymphoma

Indexed keywords

CD38 ANTIGEN; PROTEIN KINASE ZAP 70; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CELLULITIS; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COLON ADENOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GRANULOMA; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND CANCER; SENSITIVITY AND SPECIFICITY; SKIN CANCER; THYROID NODULE; VERY ELDERLY; BIOPSY; CANCER STAGING; CHROMOSOME ABERRATION; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MANAGEMENT; GENETICS; IMMUNOPHENOTYPING; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODE; MIDDLE AGED; MUTATION; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHROMOSOME ABERRATIONS; DISEASE MANAGEMENT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84906055863     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.869801     Document Type: Article

References (22)

1. Basu S, Kwee TC, Surti S, et al. Fundamentals of PET and PET/CT imaging. Ann NY Acad Sci 2011; 1228: 1-18.
2. Ansell SM, Armitage JO. Positron emission tomographic scans in lymphoma: convention and controversy. Mayo Clin Proc 2012; 87: 571-580.
3. Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluorodeoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107: 175-183.
4. Kyasa MJ, Hazlett L, Parrish RS, et al. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leuk Lymphoma 2004; 45: 507-513.
5. Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904-910.
6. Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 2010; 23: 145-153.
7. C heson B D, B ennett J M, G rever M, et al. National Cancer Institute- Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
8. H allek M, C heson B D, C atovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood 2008; 111: 5446-5456.
9. Morice WG, Kurtin PJ, Hodnefield JM, et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc 2008; 83: 776-785.
10. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
11. Bruzzi JF, Macapinlac H, Tsimberidou AM, et al. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 2006; 47: 1267-1273.
12. Papajik T, Myslivecek M, Urbanova R, et al. 2-[18F]fluoro-2- deoxy-d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter's transformation. Leuk Lymphoma 2013 Jun 14. [Epub ahead of print]
13. Gine E, Martinez A, Villamor N, et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ( " accelerated " chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 2010; 95: 1526-1533.
14. Ciccone M, Agostinelli C, Rigolin GM, et al. Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. Leukemia 2012; 26: 499-508.
15. Dewald G W, Brockman S R, Paternoster S F, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 287-295.
16. G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012; 120: 2280-2289.
17. Tschumper RC, Geyer SM, Campbell ME, et al. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. J Clin Invest 2008; 118: 306-315.
18. Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 2001; 115: 854-861.
19. R assenti L Z, H uynh L, T oy T L, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893-901.
20. Shanafelt TD, Geyer SM, Bone ND, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol 2008; 140: 537-546.
21. Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001; 12: 825-830.
22. Liu T, Weinberg JB, Davis ED, et al. The metabolic signature of CLL: enhanced glucose metabolism in a subset of high-risk CLL patients. Blood 2012; 120(Suppl. 1): Abstract 1785.